Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

O'Connor Vos has served as CEO of the WPP Health & Wellness agency since 1994.

Allergan ramps up promotion for new rosacea drug

Allergan ramps up promotion for new rosacea drug

The drugmaker began advertising for Rhofade on Facebook in early August.

Five things for pharma marketers to know: Monday, August 7, 2017

Five things for pharma marketers to know: Monday, August 7, 2017

Insurers deny coverage of generic drugs; Teva to lay off 7,000 employees; Shkreli convicted of securities fraud

Five things for pharma marketers to know: Friday, August 4, 2017

Five things for pharma marketers to know: Friday, August 4, 2017

AbbVie's new HCV drug is cheaper than Gilead's Harvoni; Lilly's experimental migraine drugs beats placebo; Fitbit to launch smartwatch

Astellas promotes Moyra Knight to comms, corporate citizenship role

Astellas promotes Moyra Knight to comms, corporate citizenship role

She will also continue to serve as president of the Astellas U.S.A. Foundation.

Five things for pharma marketers to know: Thursday, August 3, 2017

Five things for pharma marketers to know: Thursday, August 3, 2017

FDA committee votes against J&J arthritis drug; scientists successfully edit genes; Shire mulls ADHD spin off

W2O's Twist hires new president

W2O's Twist hires new president

Former Edelman executive Mary Corcoran replaces Annalise Coady, who becomes president of W2O EMEA.

Johnson & Johnson is big winner in CVS diabetes formulary changes

Johnson & Johnson is big winner in CVS diabetes formulary changes

CVS Health will remove Lilly's Jardiance in favor of J&J's Invokana.

Five things for pharma marketers to know: Wednesday, August 2, 2017

Five things for pharma marketers to know: Wednesday, August 2, 2017

Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement

Five things for pharma marketers to know: Tuesday, August 1, 2017

Five things for pharma marketers to know: Tuesday, August 1, 2017

Express Scripts removes 64 branded drugs from 2018 formulary; wearable market can regain momentum, analysts say; FDA accepts Herceptin biosimilars for review

Five things for pharma marketers to know: Monday, July 31, 2017

Five things for pharma marketers to know: Monday, July 31, 2017

FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Cannabis nutrition company focuses on education

Cannabis nutrition company focuses on education

A particular focus is put on the emerging research about cannabis and its benefits for the human body.

Five things for pharma marketers to know: Friday, July 28, 2017

Five things for pharma marketers to know: Friday, July 28, 2017

Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers

Gilead's educational campaign boosted HCV diagnosis rates for baby boomers

Gilead's educational campaign boosted HCV diagnosis rates for baby boomers

An unbranded campaign encouraging baby boomers to get tested for hepatitis C helped boost screening and diagnosis numbers, which in turn upped sales of its HCV therapies.

Neil Matheson leaves Huntsworth Health

Neil Matheson leaves Huntsworth Health

The CEO of Huntsworth's biggest and fastest-growing unit Huntsworth Health, which includes Nitrogen and Tonic Life, has departed after eight years.

Five things for pharma marketers to know: Thursday, July 27, 2017

Five things for pharma marketers to know: Thursday, July 27, 2017

Generic drugmakers reportedly seeking deals; GSK to refocus R&D; Merck and AstraZeneca to test combo cancer drug

Five things for pharma marketers to know: Wednesday, July 26, 2017

Five things for pharma marketers to know: Wednesday, July 26, 2017

Jury says AbbVie fraudulently misrepresented risks of AndroGel; Celgene settles False Claims Act lawsuit; Amgen reports more Repatha prescribers

Astellas promotes two sales veterans to new roles

Astellas promotes two sales veterans to new roles

David Musselman and Lynn Gerber are now leading sales for the company's primary care and specialty products.

Shutterstock says men are 'more responsive' to online ads

Shutterstock says men are 'more responsive' to online ads

Images that "mirror the demographic profile of their target audience" perform best, according to an eye-tracking study from picture provider Shutterstock.

Five things for pharma marketers to know: Tuesday, July 25, 2017

Five things for pharma marketers to know: Tuesday, July 25, 2017

Biogen reports better-than-expected Spinraza sales; FDA to discuss opioid prescriptions with payers; UnitedHealth Group launches media review

Cannes Lions revenues up 7% in 2017 despite delegate decline

Cannes Lions revenues up 7% in 2017 despite delegate decline

The 2017 Cannes Lions festival earned revenues of about $820 million for its owner Ascential, despite "slightly reduced" award entry and delegate numbers, the company's half-year results say.

Publicis taps Brandes as EVP of biz development

Publicis taps Brandes as EVP of biz development

He reports to Michelle Keefe, group president at Publicis Health.

Five things for pharma marketers to know: Monday, July 24, 2017

Five things for pharma marketers to know: Monday, July 24, 2017

Samsung Bioepis launches Remicade biosimilar; WHO encourages uses of generic version of Sovaldi; nearly 20 million people with HIV on treatment

WebMD sells to private equity firm KKR

WebMD sells to private equity firm KKR

The deal is worth roughly $2.8 billion.

Drugmakers face challenges marketing new heart drugs

Drugmakers face challenges marketing new heart drugs

Experts say this means drugmakers need to find new ways to communicate the value of their products.

Five things for pharma marketers to know: Friday, July 21, 2017

Five things for pharma marketers to know: Friday, July 21, 2017

The FDA to study whether linking to risk information affects patient recall; patients view docs who take industry payments as less honest; Mallinckrodt ups political donations

Are you making as much money as your peers?

Are you making as much money as your peers?

The 2017 MM&M Career & Salary Survey is open. Fill it out, and tell us about the latest salary and career trends in the pharma and healthcare sectors.

Five things for pharma marketers to know: Thursday, July 20, 2017

Five things for pharma marketers to know: Thursday, July 20, 2017

About 4.4 billion prescriptions filled in the U.S. in 2016; Sanofi and Ablynx reach I-O deal; biotech M&A slows in H1

Diabetes drugmakers partner with mobile startups to boost patient engagement

Diabetes drugmakers partner with mobile startups to boost patient engagement

Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.

GE premiers Heroines of Health video documentary in bite-size form

GE premiers Heroines of Health video documentary in bite-size form

The healthcare company released the documentary in minute-long snippets over a month, then debuted the full film this week.

Five things for pharma marketers to know: Wednesday, July 19, 2017

Five things for pharma marketers to know: Wednesday, July 19, 2017

Cost of throwing out expired drugs is $800 million per year; the FDA approves Gilead's new HCV drug; CDC says 1 in 10 Americans have diabetes

A Pornhub pro offers sex ed for seniors

A Pornhub pro offers sex ed for seniors

The 15-minute short film covers condom use, STIs, and safer sex positions for bodies that have become less flexible.

Five things for pharma marketers to know: Tuesday, July 18, 2017

Five things for pharma marketers to know: Tuesday, July 18, 2017

Novartis raises Alcon forecast; UDG acquires Cambridge BioMarketing; Spark Therapeutics receives priority review for Luxturna gene therapy

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.

One year later: How Pokémon Go leveled up AR for marketing

One year later: How Pokémon Go leveled up AR for marketing

The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.

Five things for pharma marketers to know: Monday, July 17, 2017

Five things for pharma marketers to know: Monday, July 17, 2017

More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign

Pharma spending on CME rose in 2016

Pharma spending on CME rose in 2016

It's the third year of consecutive growth for spending on accredited CME, according to the Accreditation Council for Continuing Medical Education.

Five things for pharma marketers to know: Friday, July 14, 2017

Five things for pharma marketers to know: Friday, July 14, 2017

The FDA approves J&J psoriasis drug; PARP inhibitors are not cost-effective, ICER says; Verily releases mosquitoes to combat Zika

Five things for pharma marketers to know: Thursday, July 13, 2017

Five things for pharma marketers to know: Thursday, July 13, 2017

AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge

Novartis' CAR-T therapy gets nod from FDA committee

Novartis' CAR-T therapy gets nod from FDA committee

The drugmaker is one step closer to a potential approval of its experimental cancer treatment.

Five things for pharma marketers to know: Wednesday, July 12, 2017

Five things for pharma marketers to know: Wednesday, July 12, 2017

Former sales reps for Insys plead guilty to kickback allegations; digital health funding on the rise; PhRMA launches campaign about drug costs

Stubborn politicians get flooded by women's health facts via fax

Stubborn politicians get flooded by women's health facts via fax

How Huge and the New York Civil Liberties Union used lawmakers' own antiquated ideas to support the Reproductive Health Act.

Five things for pharma marketers to know: Tuesday, July 11, 2017

Five things for pharma marketers to know: Tuesday, July 11, 2017

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

The 2017 MM&M Awards: The Shortlist

The 2017 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

Otsuka's April Mitchell on leading versus managing

Otsuka's April Mitchell on leading versus managing

When you've figured out the difference, people will walk through fire for you, a mentor once told her.

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

The relative dearth of Pharma entries, and the fact that Lions Health is very much a separate affair to the rest of the week are two factors for the Lions to keep an eye on.

Five things for pharma marketers to know: Monday, July 10, 2017

Five things for pharma marketers to know: Monday, July 10, 2017

Gottlieb calls for new opioid training for docs; FDA committee to examine Novartis' CAR-T therapy; no Viagra ads expected during NFL season

Ancestry's first work from Droga5 makes a bold statement about America's diversity

Ancestry's first work from Droga5 makes a bold statement about America's diversity

The genomics brand brings together 29 descendants of the founding fathers for an atypical July Fourth campaign.

Five things for pharma marketers to know: Friday, July 7, 2017

Five things for pharma marketers to know: Friday, July 7, 2017

Drug ads on mobile are not providing enough risk info; rare-disease drugmakers are concerned about healthcare bill; volume of opioid prescriptions drops

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

The acquisition is meant to add creative expertise to the medical communications group.

Five things for pharma marketers to know: Thursday, July 6, 2017

Five things for pharma marketers to know: Thursday, July 6, 2017

The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial

Huntsworth buys health group TCEG for $28 million and signals U.S. ambition

Huntsworth buys health group TCEG for $28 million and signals U.S. ambition

TCG generated revenues of $29.6 million in 2016.

Five things for pharma marketers to know: Wednesday, July 5, 2017

Five things for pharma marketers to know: Wednesday, July 5, 2017

Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans

Five things for pharma marketers to know: Friday, June 30, 2017

Five things for pharma marketers to know: Friday, June 30, 2017

The FDA plans to review orphan drug backlog; drugmaker supported charity helped patients pay for donor's drugs; low dose Xarelto gets Priority Review

Five things for pharma marketers to know: Thursday, June 29, 2017

Five things for pharma marketers to know: Thursday, June 29, 2017

Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Alison Lewis, the global chief marketing officer of Johnson & Johnson consumer division, has little appetite for new flavours and variants but instead wants to rethink innovation as a means to solve consumer problems.

Five things for pharma marketers to know: Wednesday, June 28, 2017

Five things for pharma marketers to know: Wednesday, June 28, 2017

Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck's CETP inhibitor anacetrapib and Novartis' monoclonal antibody ACZ885 hit their primary goals in late-stage cardiovascular outcomes trials, both unexpectedly positive results that are heating up this category.

Pfizer celebrates the faces behind its vaccines with documentary

Pfizer celebrates the faces behind its vaccines with documentary

The video is part of Pfizer's ongoing corporate ad campaign Before it Became a Medicine.

Five things for pharma marketers to know: Tuesday, June 27, 2017

Five things for pharma marketers to know: Tuesday, June 27, 2017

Merck announces positive trial results for CETP inhibitor; Purdue Pharma defends withholding of OxyContin marketing material; Roche's experimental haemophilia drug significantly cuts bleed rate

LiquidHub acquires Eveo to form new health offering

LiquidHub acquires Eveo to form new health offering

The agency founded by Olivier Zitoun in 1999 has been snapped up as part of LiquidHub's push to offer multi-disciplinary capabilities.

Standing out in crowded cancer market

Standing out in crowded cancer market

Opdivo's marketing campaigns need to both market to and educate consumers about the new immunotherapy cancer treatment.

Five things for pharma marketers to know: Monday, June 26, 2017

Five things for pharma marketers to know: Monday, June 26, 2017

The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public

PulseCX promotes David Zaritsky to CEO

PulseCX promotes David Zaritsky to CEO

Zaritsky succeeds Jay Bolling, who becomes executive chairman

Five things for pharma marketers to know: Friday, June 23, 2017

Five things for pharma marketers to know: Friday, June 23, 2017

Novartis drug prevents heart attacks and strokes, per trial; Senate lawmakers unveil healthcare bill; Pfizer receives CRL for Epogen biosimilar

Five things for pharma marketers to know: Thursday, June 22, 2017

Five things for pharma marketers to know: Thursday, June 22, 2017

The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement

The FDA attempts to understand how disclosures affect drug ads

The FDA attempts to understand how disclosures affect drug ads

The FDA recently proposed studies designed to determine how disclosures in drug ads affect how viewers frame information.

Five things for pharma marketers to know: Wednesday, June 21, 2017

Five things for pharma marketers to know: Wednesday, June 21, 2017

Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections

How Zicam made the most of TV's cold season

How Zicam made the most of TV's cold season

How Zicam proved that there is a better, more data-driven approach to buying and measuring TV advertising..

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Area 23's Healthcare Agency of the Year win was four years in the making

Area 23's Healthcare Agency of the Year win was four years in the making

The FCB Health network won big this year with several campaigns, including work featuring a bra that detects breast cancer and an awareness campaign for human trafficking.

Five things for pharma marketers to know: Tuesday, June 20, 2017

Five things for pharma marketers to know: Tuesday, June 20, 2017

Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers are increasingly facing blame from regulators, lawmakers, and the public as the list of lawsuits and investigations at the state and local levels grows.

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Under siege from intense competition and the rise of value-based contracts, diabetes drugmakers look to outcomes data to stand out.

Five things for pharma marketers to know: Monday, June 19, 2017

Five things for pharma marketers to know: Monday, June 19, 2017

Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors

Day 2 at Lions Health: Watson's got its eye on you, Cannes

Day 2 at Lions Health: Watson's got its eye on you, Cannes

There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.

Lions Health: The 2017 health and wellness winners

Lions Health: The 2017 health and wellness winners

An Australian road safety campaign caught the eyes of the judges.

Lions Health: The 2017 pharma winners

Lions Health: The 2017 pharma winners

A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.

Lions Health jury declines to award a pharma Grand Prix

Lions Health jury declines to award a pharma Grand Prix

The jury said the year's best work in the category was a public-health campaign.

U.S. campaigns make up one-third of Lions Health pharma shortlist

U.S. campaigns make up one-third of Lions Health pharma shortlist

In the Lions Health pharma shortlist, released Saturday morning, five branded campaign made it through the judging process for the branded prescription categories.

Five things for pharma marketers to know: Friday, June 16, 2017

Five things for pharma marketers to know: Friday, June 16, 2017

Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO

Five things for pharma marketers to know: Thursday, June 15, 2017

Five things for pharma marketers to know: Thursday, June 15, 2017

Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research

AMA votes to require disclosure of drug prices in DTC ads

AMA votes to require disclosure of drug prices in DTC ads

The association also recommended that the Centers for Medicare and Medicaid Services negotiate drug prices.

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

The FDA-approved app will allow MS patients to share their medication injection history with HCPs.

Half of clinical-trial sites offer free transportation to patients

Half of clinical-trial sites offer free transportation to patients

Consent forms and reimbursement are the main deterrents of offering the service.

Five things for pharma marketers to know: Wednesday, June 14, 2017

Five things for pharma marketers to know: Wednesday, June 14, 2017

Sanofi to boost investment in biologics R&D; Sage's awareness campaign criticized; PatientsLikeMe poll finds 95% of patients want some costs of drugs covered

Five things for pharma marketers to know: Tuesday, June 13, 2017

Five things for pharma marketers to know: Tuesday, June 13, 2017

Alkermes lobbies lawmakers on its opioid addiction drug; rep salaries rise; SCOTUS rules in favor of Sandoz in biosimilar suit

Five things for pharma marketers to know: Monday, June 12, 2017

Five things for pharma marketers to know: Monday, June 12, 2017

Teva gets FDA approval for Truvada generic; the FDA rejects Coherus' Neulasta biosimilar; only 17% of Americans find health industries to be innovative

Healthcare brands turn to emotion, to better tell their stories

Healthcare brands turn to emotion, to better tell their stories

It's never been easy for pharmaceutical companies or healthcare brands to authentically engage with patients or with doctors.

How Dana Maiman does Cannes

How Dana Maiman does Cannes

The CEO of FCB Health shares her gelato secrets and talks about why this year is truly the year of healthcare.

How Graham Mills does Cannes

How Graham Mills does Cannes

He buys macarons to make friends and finds that Cannes is an "extraordinary opportunity to rewire your brain."

How Ritesh Patel does Cannes

How Ritesh Patel does Cannes

Words of the wise: Vacant the Gutter Bar by 2 a.m., and make sure to bring flip flops and go walk on the beach.

Astellas reprimanded by U.K. drug regulator

Astellas reprimanded by U.K. drug regulator

The drugmaker has been handed a "public reprimand" by the U.K.'s Prescription Medicines Code of Practice Authority after the creative director of an unnamed agency used the company's patient support materials on its website.

Five things for pharma marketers to know: Friday, June 9, 2017

Five things for pharma marketers to know: Friday, June 9, 2017

The FDA asks Endo to take opioid off the market; Lilly partners with Swiss biotech; House committee advances PDUFA bill — without off-label provision

Live @ the MM&M Hall of Femme: Women talk about taking action to bridge the gender gap

Live @ the MM&M Hall of Femme: Women talk about taking action to bridge the gender gap

Executives discussed the challenges and opportunities they have faced as women.

Five things for pharma marketers to know: Thursday, June 8, 2017

Five things for pharma marketers to know: Thursday, June 8, 2017

Novartis CAR-T drug boasts competitive response rates; WPP reports slowing sales for healthcare business; AZ sells migraine drug

How should pharma market to millennials?

How should pharma market to millennials?

The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.

Five things for pharma marketers to know: Wednesday, June 7, 2017

Five things for pharma marketers to know: Wednesday, June 7, 2017

Pfizer receives breakthrough designation for experimental rare disease drug; Endocyte cuts 30 jobs; AbbVie RA drug meets Phase-III goals

PDUFA amendment would broaden off-label rules

PDUFA amendment would broaden off-label rules

The bill, introduced in March, is being considered as an amendment in the upcoming PDUFA reauthorization legislation.